NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/09/2023
Voltar para busca
Dado oficial do USPTO
A ANIVIVE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
65
Atualização mais recente
26/09/2023
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
24/04/2018
Data de registro
26/09/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/09/2023
Última transação
26/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
05/01/2021
Primeiro uso no comércio
05/01/2021
Código do desenho
3
Tipo de titular
03
Localização do titular
Long Beach, CA
Examinador
O'BRIEN, JENNIFER
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of dotted "A" with the word "ANIVIVE".
Titulares e representantes
Titulares
Anivive Lifesciences, Inc
Representantes
Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutraceuticals for the purpose of treating animal diseasesanimal conditions and animal illnesses in the field of veterinary medicine in the nature of autoimmune disordersoncologic disordersrenal and urinary tract disordersneurologic disordersmusculoskeletal disordersinfectious disease disordersdermatologic disordersophthalmic disorderscardiovascular disordersrespiratory disordersendocrine disordersmetabolic disorders including obesitygastrointestinal disorders; Pharmaceuticalspharmaceuticals for the purpose of treating animal diseasesanimal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disordersoncologic disordersrenal and urinary tract disordersneurologic disordersmusculoskeletal disordersinfectious disease disordersdermatologic disordersophthalmic disorderscardiovascular disordersrespiratory disordersendocrine disordersmetabolic disorders including obesitygastrointestinal disorders; Vaccines in the field of veterinary medicine; Therapeutic pharmaceuticals for the purpose of treating animal diseasesanimal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disordersoncologic disordersrenal and urinary tract disordersneurologic disordersmusculoskeletal disordersinfectious disease disordersdermatologic disordersophthalmic disorderscardiovascular disordersrespiratory disordersendocrine disordersmetabolic disorders including obesitygastrointestinal disorders
Classe 42
Drug discovery services for veterinary medicine; providing pharmaceutical and medical research services and clinicalmedical and scientific research information in the field of animal health; analysis services for veterinary medicineclinicalmedical and scientific research; obtainingrecordinganalyzingreporting and modeling data for animal health purposeselectronic monitoring and reporting of clinical informationagesexbreedneuter statusbody weightbody condition scoreblood pressureheart ratefrequency and character of respirationappetitepresence or absence of vomitingactivity levelfood and water intakefrequency and character of urination and defecationof animalsusing computers or sensors; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for use in database managementfor use as a spreadsheetfor word processingfor statistical analysisdata aggregationdata processingreport generationdata sharingremote data managementremote project managementdata analysis in the field of veterinary medicine for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for assisting in drug discovery in the nature of managing clinical trials for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software to facilitate ordering and delivery of medications and treatment to animal ownersdistributors and veterinary health care providers for animal health purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
65 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/09/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23/08/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
22/08/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
31/07/2023
IUAF
USE AMENDMENT FILED
14/07/2023
EISU
TEAS STATEMENT OF USE RECEIVED
14/07/2023
DOCK
ASSIGNED TO EXAMINER
01/03/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/02/2023
EX5G
SOU EXTENSION 5 GRANTED
07/02/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
26/01/2023
EXT5
SOU EXTENSION 5 FILED
11/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/06/2022
EX4G
SOU EXTENSION 4 GRANTED
17/06/2022
EXT4
SOU EXTENSION 4 FILED
17/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
17/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/01/2022
EX3G
SOU EXTENSION 3 GRANTED
07/01/2022
EXT3
SOU EXTENSION 3 FILED
07/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/07/2021
EX2G
SOU EXTENSION 2 GRANTED
01/07/2021
EXT2
SOU EXTENSION 2 FILED
01/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/01/2021
EX1G
SOU EXTENSION 1 GRANTED
07/01/2021
EXT1
SOU EXTENSION 1 FILED
07/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/05/2020
PUBO
PUBLISHED FOR OPPOSITION
19/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/04/2020
EXPT
EXPARTE APPEAL TERMINATED
13/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
13/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
13/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/03/2020
ALIE
ASSIGNED TO LIE
31/03/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/03/2020
EXPI
EX PARTE APPEAL-INSTITUTED
23/03/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
23/03/2020
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
23/03/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/09/2019
GNFR
FINAL REFUSAL E-MAILED
25/09/2019
CNFR
FINAL REFUSAL WRITTEN
25/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2019
GNRT
NON-FINAL ACTION E-MAILED
04/03/2019
CNRT
NON-FINAL ACTION WRITTEN
04/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
16/08/2018
GPRA
PRIORITY ACTION E-MAILED
16/08/2018
CPRA
PRIORITY ACTION WRITTEN
16/08/2018
DOCK
ASSIGNED TO EXAMINER
14/08/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2018
NWAP
NEW APPLICATION ENTERED
27/04/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace A ANIVIVE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.